← Back to Search

Observational for Bladder Cancer

N/A
Recruiting
Led By Mark D. Tyson, M.D., M.P.H.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline, 6, 12, 24, and 36 months
Awards & highlights

Study Summary

This study evaluates the effect of bladder cancer treatment on quality of life.

Eligible Conditions
  • Bladder Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline, 6, 12, 24, and 36 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline, 6, 12, 24, and 36 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in quality of life outcomes - Bladder Cancer Index
Change in quality of life outcomes - PROMIS-29
Patient level characteristics

Trial Design

1Treatment groups
Experimental Treatment
Group I: ObservationalExperimental Treatment1 Intervention
Patients complete surveys and also have their medical records reviewed on study.

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,209 Previous Clinical Trials
3,766,430 Total Patients Enrolled
Mark D. Tyson, M.D., M.P.H.Principal InvestigatorMayo Clinic
1 Previous Clinical Trials
107 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~326 spots leftby Jan 2029